Advertisement

Emergency Medicine

Home Emergency Medicine
Among prostate cancer patients

Risk for SARS-CoV-2 Lower for Prostate Cancer Patients on ADT

Risk reduced fourfold with androgen-deprivation therapy versus other treatment for prostate cancer
The overall infection fatality rate among symptomatic COVID-19 cases in the United States is estimated at 1.3 percent

Symptomatic COVID-19 Infection Fatality Rate 1.3 Percent in U.S.

County-specific infection fatality rates for symptomatic cases varied from 0.5 to 3.6 percent
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of May 4 to 8

Physician’s Briefing Weekly Coronavirus Roundup

Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Up to 75

Deaths of Despair Likely to Increase During Pandemic

Authors propose policies addressing employment; access to care; and integrated behavioral, clinical care
The New York State Department of Health issued an advisory on May 6 regarding cases of pediatric multisystem inflammatory syndrome potentially associated with COVID-19.

New York State Reports Cases of Pediatric Inflammatory Syndrome Tied to COVID-19

Pediatric patients presenting with compatible symptoms should undergo SARS-CoV-2 testing
For patients hospitalized with COVID-19

Anticoagulation May Improve Outcomes in COVID-19 Patients

Longer duration of AC treatment linked to reduced risk for mortality in hospitalized patients
Gastrointestinal symptoms are seen in less than 10 percent of patients with COVID-19

GI Symptoms Seen in Less Than 10 Percent of COVID-19 Patients

Outpatients with new-onset GI symptoms should be monitored for COVID-19 symptoms
Endovascular thrombectomy alone is noninferior to endovascular thrombectomy preceded by intravenous alteplase for patients with acute ischemic stroke from large-vessel occlusion

Endovascular Thrombectomy Alone Noninferior in Ischemic Stroke

Noninferior to IV alteplase followed by endovascular thrombectomy for acute ischemic stroke
Age and underlying cardiovascular disease are associated with in-hospital mortality in COVID-19

ACE Inhibitors, ARBs Not Linked to In-Hospital COVID-19 Death

Risk for in-hospital death increased with age >65, underlying cardiovascular disease, COPD, smoking
In an evidence-based guideline developed by an international team of physicians

Guideline Issued for Nonsevere, Severe COVID-19 Therapy

Corticosteroids recommended for severe COVID-19 with ARDS but not severe COVID-19 without ARDS